Retinal nerve fiber layer and ganglion cell complex thickness in patients with type 2 diabetes mellitus.

Aim: The aim of the following study is to evaluate the retinal nerve fiber layer (RNFL) and ganglion cell complex (GCC) thickness in patients with type 2 diabetes mellitus (DM).

Materials And Methods: Average, inferior, and superior values of RNFL and GCC thickness were measured in 123 patients using spectral domain optical coherence tomography. The values of participants with DM were compared to controls.

Central macular thickness in patients with type 2 diabetes mellitus without clinical retinopathy.

Background: An increase in macular thickness due to fluid accumulation in the macula in patients with diabetes mellitus. Optical coherence tomography (OCT) has been shown to be highly reproducible in measuring macular thickness in normal individuals and diabetic patients. OCT can detect subtle changes of macular thickness.

Effect of intracameral carbachol given during cataract surgery on macular thickness.

To evaluate the effect of intracameral carbachol on foveal thickness in patients who underwent uneventful cataract surgery. This retrospective study included two groups: the study group patients (group 1, n = 47 eyes) had uneventful cataract surgery and received only carbachol 0.01 % for miosis; the control group patients (group 2, n = 49 eyes) had uneventful cataract surgery without carbachol or any intracameral medication(s).

Foveal and parafoveal retinal thickness in healthy pregnant women in their last trimester.

Purpose: The inspection of foveal and parafoveal thickness in healthy pregnant women in the last trimester.

Materials And Methods: This study included 40 healthy pregnant women in their last trimester (study group: 40 women, 80 eyes) and 37 nonpregnant women (control group: 37 women, 74 eyes). Visual acuity, intraocular pressure, slit lamp examination of anterior and posterior segments, and visual field examination with automated perimetry were performed in both groups.

Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results.

Purpose: To present the functional and anatomic changes after intravitreal bevacizumab in eyes with macular edema (ME) due to branch retinal vein occlusion (BRVO).

Design: The study was a retrospective study.

Materials And Methods: The study included 31 patients with ME due to BRVO.